Exelixis (EXEL) Change in Accured Expenses (2010 - 2026)

Exelixis (EXEL) recorded quarterly Change in Accured Expenses of $4.0 million in Q2 2026, up 1039.15% quarter-over-quarter from $355000.0 in Q1 2026, and down 12.18% on a YoY basis from $4.6 million in Q2 2025.

Exelixis (EXEL) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Exelixis' Change in Accured Expenses history runs 16 years deep, the most recent figure standing at $4.0 million for Q2 2026.

  • In Q2 2026, Change in Accured Expenses fell 12.18% year-over-year to $4.0 million; the TTM figure through Apr 2026 stood at $1.3 million (down 83.85% YoY), while the FY2026 annual figure was $1.9 million, up 1374.5% from the prior year.
  • Change in Accured Expenses was $4.0 million for Q2 2026 at Exelixis, up from $355000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $5.1 million in Q2 2023 to a low of -$54.3 million in Q2 2022.
  • Historically, Change in Accured Expenses has averaged -$3.4 million across 5 years, with a median of $604500.0 in 2025.
  • The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses plunged 5499.1% in 2022, then surged 223.48% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$54.3 million in 2022, then soared by 100.49% to $264000.0 in 2023, then jumped by 410.23% to $1.3 million in 2024, then slumped by 32.96% to $903000.0 in 2025, then soared by 347.84% to $4.0 million in 2026.
  • The last three Change in Accured Expenses figures came in at $4.0 million (Q2 2026), $355000.0 (Q1 2026), and $903000.0 (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 931,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 644,700.00
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 70.50 Mn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn 4.04 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 4.04 Mn
Apr 3, 2026 4.04 Mn
Jan 2, 2026 355,000.00
Jan 2, 2026 355,000.00
Oct 3, 2025 903,000.00
Oct 3, 2025 903,000.00
Jul 4, 2025 -3.96 Mn
Jul 4, 2025 -3.96 Mn
Apr 4, 2025 4.61 Mn
Apr 4, 2025 4.61 Mn
Jan 3, 2025 854,000.00
Jan 3, 2025 854,000.00
Sep 27, 2024 1.35 Mn
Sep 27, 2024 1.35 Mn
Jun 28, 2024 1.48 Mn
Jun 28, 2024 1.48 Mn
Mar 29, 2024 -3.83 Mn
Mar 29, 2024 -3.83 Mn
Dec 29, 2023 264,000.00
Dec 29, 2023 264,000.00